| Mrs Crystal Tomaino, | |
|
131 Pleasant Dr, Aliquippa, PA 15001-1384 | |
| (724) 378-5400 | |
| Not Available |
| Full Name | Mrs Crystal Tomaino |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 131 Pleasant Dr, Aliquippa, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568058543 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | SP022805 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Personal Care Medical Associates, Llc | 1456344084 | 34 |
News Archive
A new finding in neuroscience for the first time points to a developmental mechanism linking the disease-causing mutation in an autism-related disorder, Timothy syndrome, and observed defects in brain wiring, according to a study led by scientist Ricardo Dolmetsch and published online yesterday in Nature Neuroscience.
President Barack Obama offers sharp critcism of the GOP budget plan, which passed the House on a near-party-line vote last week and which has been embraced by GOP presidential hopefuls. Although the plan, written by House Budget Chairman Paul Ryan, R-Wisc., would greatly expand the role of private insurers in Medicare, the insurance industry has been mostly silent as well.
Golden Meditech Holdings Limited, China's leading integrated healthcare enterprise, is pleased to announce that the Group will acquire the remaining interests in the Group's Chinese herbal medicine business for a total consideration of HK$90 million in shares.
Millions of women suffer from unexplained vulvar pain so severe it can make intercourse, exercise and even sitting unbearable. New research now shows that women with this painful vaginal condition known as vulvodynia are two to three times more likely to also have one or more other chronic pain conditions, including irritable bowel syndrome, fibromyalgia (musculoskeletal pain) and interstitial cystitis (bladder pain).
Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients. This new clinical study follows a completed Phase 2 trial and builds on experience gained in that trial, by enhancing the dosing regimen and optimizing the duration of patient follow up.
› Verified 3 days ago
| Entity Name | Personal Care Medical Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922427962 PECOS PAC ID: 1456344084 Enrollment ID: O20040407001274 |
News Archive
A new finding in neuroscience for the first time points to a developmental mechanism linking the disease-causing mutation in an autism-related disorder, Timothy syndrome, and observed defects in brain wiring, according to a study led by scientist Ricardo Dolmetsch and published online yesterday in Nature Neuroscience.
President Barack Obama offers sharp critcism of the GOP budget plan, which passed the House on a near-party-line vote last week and which has been embraced by GOP presidential hopefuls. Although the plan, written by House Budget Chairman Paul Ryan, R-Wisc., would greatly expand the role of private insurers in Medicare, the insurance industry has been mostly silent as well.
Golden Meditech Holdings Limited, China's leading integrated healthcare enterprise, is pleased to announce that the Group will acquire the remaining interests in the Group's Chinese herbal medicine business for a total consideration of HK$90 million in shares.
Millions of women suffer from unexplained vulvar pain so severe it can make intercourse, exercise and even sitting unbearable. New research now shows that women with this painful vaginal condition known as vulvodynia are two to three times more likely to also have one or more other chronic pain conditions, including irritable bowel syndrome, fibromyalgia (musculoskeletal pain) and interstitial cystitis (bladder pain).
Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients. This new clinical study follows a completed Phase 2 trial and builds on experience gained in that trial, by enhancing the dosing regimen and optimizing the duration of patient follow up.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Crystal Tomaino, 3716 W 6th Ave, Beaver Falls, PA 15010-1919 Ph: (724) 650-0134 | Mrs Crystal Tomaino, 131 Pleasant Dr, Aliquippa, PA 15001-1384 Ph: (724) 378-5400 |
News Archive
A new finding in neuroscience for the first time points to a developmental mechanism linking the disease-causing mutation in an autism-related disorder, Timothy syndrome, and observed defects in brain wiring, according to a study led by scientist Ricardo Dolmetsch and published online yesterday in Nature Neuroscience.
President Barack Obama offers sharp critcism of the GOP budget plan, which passed the House on a near-party-line vote last week and which has been embraced by GOP presidential hopefuls. Although the plan, written by House Budget Chairman Paul Ryan, R-Wisc., would greatly expand the role of private insurers in Medicare, the insurance industry has been mostly silent as well.
Golden Meditech Holdings Limited, China's leading integrated healthcare enterprise, is pleased to announce that the Group will acquire the remaining interests in the Group's Chinese herbal medicine business for a total consideration of HK$90 million in shares.
Millions of women suffer from unexplained vulvar pain so severe it can make intercourse, exercise and even sitting unbearable. New research now shows that women with this painful vaginal condition known as vulvodynia are two to three times more likely to also have one or more other chronic pain conditions, including irritable bowel syndrome, fibromyalgia (musculoskeletal pain) and interstitial cystitis (bladder pain).
Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients. This new clinical study follows a completed Phase 2 trial and builds on experience gained in that trial, by enhancing the dosing regimen and optimizing the duration of patient follow up.
› Verified 3 days ago
Tammy M Ronstadt, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5000 Industrial Blvd, Aliquippa, PA 15001 Phone: 412-749-6739 Fax: 724-770-7931 | |
Patricia M Gordon, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2349 Mill St, Aliquippa, PA 15001 Phone: 878-201-3312 Fax: 878-201-3584 | |
Carla Denne Tomas, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2349 Mill St, Aliquippa, PA 15001 Phone: 878-201-3312 | |
Katie Beth Manni, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 188 Edgewood St, Aliquippa, PA 15001 Phone: 724-914-0283 | |
Shannon Stefan Robertson, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2719 Brodhead Rd Ste 190, Aliquippa, PA 15001 Phone: 724-419-9200 Fax: 724-419-9202 | |
Ms. Hanna Boyd, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5000 Industrial Blvd, Aliquippa, PA 15001 Phone: 724-773-6464 | |
Linda Eileen Lombard-ash, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Aliquippa, PA 15001 Phone: 724-375-8110 Fax: 724-375-2435 |